Even as mRNA specialist BioNTech plants its manufacturing flag on continents around the globe, the company is still advancing production capabilities at home. Thursday, BioNTech said it finished ...
BioNTech (NASDAQ:BNTX) has completed the building of its first plasmid DNA manufacturing facility in Marburg, Germany. Plasmid DNA are the building blocks for the manufacturing of mRNA-based vaccines ...
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback